Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Stimulant treatment in Maryland public schools
Autore:
Safer, DJ; Malever, M;
Indirizzi:
Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21205 USA Johns Hopkins Med Inst Baltimore MD USA 21205 at, Baltimore, MD 21205 USA Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA Johns HopkinsMed Inst Baltimore MD USA 21205 at, Baltimore, MD 21205 USA Maryland State Dept Educ, Baltimore, MD USA Maryland State Dept Educ Baltimore MD USA e Dept Educ, Baltimore, MD USA
Titolo Testata:
PEDIATRICS
fascicolo: 3, volume: 106, anno: 2000,
pagine: 533 - 539
SICI:
0031-4005(200009)106:3<533:STIMPS>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
ATTENTION-DEFICIT-HYPERACTIVITY; TEACHER-RATING-SCALE; DISORDER; CHILDREN; METHYLPHENIDATE; STUDENTS; YOUTHS; MEDICATIONS;
Keywords:
attention deficit hyperactivity disorder; methylphenidate; stimulant medication; pharmacoepidemiology;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
40
Recensione:
Indirizzi per estratti:
Indirizzo: Safer, DJ 7702 Dunmanway, Baltimore, MD 21222 USA 7702 Dunmanway Baltimore MD USA 21222 , Baltimore, MD 21222 USA
Citazione:
D.J. Safer e M. Malever, "Stimulant treatment in Maryland public schools", PEDIATRICS, 106(3), 2000, pp. 533-539

Abstract

Objective. A statewide school survey was performed to provide naturalisticdata on the prevalence of medication administered to Maryland public school students for the treatment of attention deficit hyperactivity disorder (ADHD) to clarify the concern of some state legislators about stimulant treatment for youths. Methods. In April 1998, school nurses supervised a survey of all Maryland public school students medicated during school hours for ADHD. The data collected on these students included: type of medication administered, gender,school level, race/ethnicity, special education and Section 504 status, and the specialist of the prescriber. Results. Of the 816 465 students surveyed, 20 050 (2.46%) received methylphenidate and 3721 (0.46%) received other medications for ADHD. Other major findings were: 1) methylphenidate constituted 84% of all the medication administered for ADHD; 2) the male: female ratio of the medication's recipients was 3.5:1 and 4.3:1 in elementary and secondary school, respectively; 3) black and Hispanic students received methylphenidate at approximately half the rate of their white counterparts; 4) 45% of all students receiving methylphenidate had special education status and an additional 8% had Section 504 status; and 5) nurse practitioners were the prescribers of 3% of the methylphenidate prescribed to Maryland students. Conclusions. This large, population-based, point prevalence study of medication administered to students for ADHD adds new and updated findings on prevalence variations, rates for minority and special education/ Section 504 students, and specialty prescriber rates.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/20 alle ore 16:13:22